The global SPECT radiopharmaceuticals market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing demand for SPECT radiopharmaceuticals in oncology and cardiology applications. Technetiu99, thalliu201, galliu67, iodin123 and indiu111 are some of the major types of SPECT radiopharmaceuticals that are used in various applications such as oncology and cardiology.
North America dominates the global SPECT radiopharmaceuticals market with a share of over 40%. This can be attributed to the presence of major players in this region such as GE Healthcare (US), Siemens Healthcare (Germany) and Philips Healthcare (Netherlands). Europe follows North America with a share close to 30%. Asia Pacific is expected to witness significant growth during the forecast period owing to its large population base coupled with an increase in awareness about cancer treatment among people living there.
-The SPECT Radiopharmaceuticals market is expected to grow at a CAGR of 5.5% from 2017 to 2022.
-The growth of the SPECT Radiopharmaceuticals market is driven by the increasing number of patients with cancer and other diseases, which in turn leads to an increase in demand for diagnostic imaging procedures.
-Increasing prevalence of chronic diseases such as diabetes and obesity are also driving the growth of the SPECT Radiopharmaceuticals market.
Industry Growth Insights published a new data on “SPECT Radiopharmaceuticals Market”. The research report is titled “SPECT Radiopharmaceuticals Market research by Types (Technetium-99, Thallium-201, Gallium-67, Iodine-123, Indium-111, Other), By Applications (Oncology, Cardiology, Thyroid), By Players/Companies GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Eczacibasi-Monrol Nuclear Products, IBA Molecular Imaging, Jubilant Life Sciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
SPECT Radiopharmaceuticals Market Research Report
By Type
Technetium-99, Thallium-201, Gallium-67, Iodine-123, Indium-111, Other
By Application
Oncology, Cardiology, Thyroid
By Companies
GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Eczacibasi-Monrol Nuclear Products, IBA Molecular Imaging, Jubilant Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global SPECT Radiopharmaceuticals Market Report Segments:
The global SPECT Radiopharmaceuticals market is segmented on the basis of:
Types
Technetium-99, Thallium-201, Gallium-67, Iodine-123, Indium-111, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cardiology, Thyroid
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Cardinal Health
- Lantheus Medical Imaging
- Bracco Imaging
- Eczacibasi-Monrol Nuclear Products
- IBA Molecular Imaging
- Jubilant Life Sciences
Highlights of The SPECT Radiopharmaceuticals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Technetium-99
- Thallium-201
- Gallium-67
- Iodine-123
- Indium-111
- Other
- By Application:
- Oncology
- Cardiology
- Thyroid
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the SPECT Radiopharmaceuticals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
SPECT radiopharmaceuticals are radioactive substances that are used in medical imaging to create images of the body.
Some of the major companies in the spect radiopharmaceuticals market are GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Eczacibasi-Monrol Nuclear Products, IBA Molecular Imaging, Jubilant Life Sciences.
The spect radiopharmaceuticals market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. SPECT Radiopharmaceuticals Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. SPECT Radiopharmaceuticals Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. SPECT Radiopharmaceuticals Market - Supply Chain
4.5. Global SPECT Radiopharmaceuticals Market Forecast
4.5.1. SPECT Radiopharmaceuticals Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. SPECT Radiopharmaceuticals Market Size (000 Units) and Y-o-Y Growth
4.5.3. SPECT Radiopharmaceuticals Market Absolute $ Opportunity
5. Global SPECT Radiopharmaceuticals Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. SPECT Radiopharmaceuticals Market Size and Volume Forecast by Type
5.3.1. Technetium-99
5.3.2. Thallium-201
5.3.3. Gallium-67
5.3.4. Iodine-123
5.3.5. Indium-111
5.3.6. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global SPECT Radiopharmaceuticals Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. SPECT Radiopharmaceuticals Market Size and Volume Forecast by Application
6.3.1. Oncology
6.3.2. Cardiology
6.3.3. Thyroid
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global SPECT Radiopharmaceuticals Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. SPECT Radiopharmaceuticals Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global SPECT Radiopharmaceuticals Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. SPECT Radiopharmaceuticals Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global SPECT Radiopharmaceuticals Demand Share Forecast, 2019-2026
9. North America SPECT Radiopharmaceuticals Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America SPECT Radiopharmaceuticals Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America SPECT Radiopharmaceuticals Market Size and Volume Forecast by Application
9.4.1. Oncology
9.4.2. Cardiology
9.4.3. Thyroid
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America SPECT Radiopharmaceuticals Market Size and Volume Forecast by Type
9.7.1. Technetium-99
9.7.2. Thallium-201
9.7.3. Gallium-67
9.7.4. Iodine-123
9.7.5. Indium-111
9.7.6. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America SPECT Radiopharmaceuticals Demand Share Forecast, 2019-2026
10. Latin America SPECT Radiopharmaceuticals Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America SPECT Radiopharmaceuticals Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America SPECT Radiopharmaceuticals Market Size and Volume Forecast by Application
10.4.1. Oncology
10.4.2. Cardiology
10.4.3. Thyroid
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America SPECT Radiopharmaceuticals Market Size and Volume Forecast by Type
10.7.1. Technetium-99
10.7.2. Thallium-201
10.7.3. Gallium-67
10.7.4. Iodine-123
10.7.5. Indium-111
10.7.6. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America SPECT Radiopharmaceuticals Demand Share Forecast, 2019-2026
11. Europe SPECT Radiopharmaceuticals Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe SPECT Radiopharmaceuticals Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe SPECT Radiopharmaceuticals Market Size and Volume Forecast by Application
11.4.1. Oncology
11.4.2. Cardiology
11.4.3. Thyroid
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe SPECT Radiopharmaceuticals Market Size and Volume Forecast by Type
11.7.1. Technetium-99
11.7.2. Thallium-201
11.7.3. Gallium-67
11.7.4. Iodine-123
11.7.5. Indium-111
11.7.6. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe SPECT Radiopharmaceuticals Demand Share, 2019-2026
12. Asia Pacific SPECT Radiopharmaceuticals Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific SPECT Radiopharmaceuticals Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific SPECT Radiopharmaceuticals Market Size and Volume Forecast by Application
12.4.1. Oncology
12.4.2. Cardiology
12.4.3. Thyroid
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific SPECT Radiopharmaceuticals Market Size and Volume Forecast by Type
12.7.1. Technetium-99
12.7.2. Thallium-201
12.7.3. Gallium-67
12.7.4. Iodine-123
12.7.5. Indium-111
12.7.6. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific SPECT Radiopharmaceuticals Demand Share, 2019-2026
13. Middle East & Africa SPECT Radiopharmaceuticals Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa SPECT Radiopharmaceuticals Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa SPECT Radiopharmaceuticals Market Size and Volume Forecast by Application
13.4.1. Oncology
13.4.2. Cardiology
13.4.3. Thyroid
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa SPECT Radiopharmaceuticals Market Size and Volume Forecast by Type
13.7.1. Technetium-99
13.7.2. Thallium-201
13.7.3. Gallium-67
13.7.4. Iodine-123
13.7.5. Indium-111
13.7.6. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa SPECT Radiopharmaceuticals Demand Share, 2019-2026
14. Competition Landscape
14.1. Global SPECT Radiopharmaceuticals Market: Market Share Analysis
14.2. SPECT Radiopharmaceuticals Distributors and Customers
14.3. SPECT Radiopharmaceuticals Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GE Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cardinal Health
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Lantheus Medical Imaging
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bracco Imaging
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eczacibasi-Monrol Nuclear Products
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. IBA Molecular Imaging
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Jubilant Life Sciences
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
